1. Home
  2. RLMD vs TOMZ Comparison

RLMD vs TOMZ Comparison

Compare RLMD & TOMZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RLMD
  • TOMZ
  • Stock Information
  • Founded
  • RLMD 2004
  • TOMZ 1979
  • Country
  • RLMD United States
  • TOMZ United States
  • Employees
  • RLMD N/A
  • TOMZ N/A
  • Industry
  • RLMD Biotechnology: Pharmaceutical Preparations
  • TOMZ Diversified Commercial Services
  • Sector
  • RLMD Health Care
  • TOMZ Finance
  • Exchange
  • RLMD Nasdaq
  • TOMZ Nasdaq
  • Market Cap
  • RLMD 22.0M
  • TOMZ 22.6M
  • IPO Year
  • RLMD N/A
  • TOMZ N/A
  • Fundamental
  • Price
  • RLMD $0.67
  • TOMZ $1.04
  • Analyst Decision
  • RLMD Buy
  • TOMZ Strong Buy
  • Analyst Count
  • RLMD 3
  • TOMZ 1
  • Target Price
  • RLMD $5.00
  • TOMZ $3.50
  • AVG Volume (30 Days)
  • RLMD 478.7K
  • TOMZ 35.3K
  • Earning Date
  • RLMD 08-06-2025
  • TOMZ 07-31-2025
  • Dividend Yield
  • RLMD N/A
  • TOMZ N/A
  • EPS Growth
  • RLMD N/A
  • TOMZ N/A
  • EPS
  • RLMD N/A
  • TOMZ N/A
  • Revenue
  • RLMD N/A
  • TOMZ $8,201,313.00
  • Revenue This Year
  • RLMD N/A
  • TOMZ $3.66
  • Revenue Next Year
  • RLMD N/A
  • TOMZ $139.63
  • P/E Ratio
  • RLMD N/A
  • TOMZ N/A
  • Revenue Growth
  • RLMD N/A
  • TOMZ 19.09
  • 52 Week Low
  • RLMD $0.24
  • TOMZ $0.60
  • 52 Week High
  • RLMD $4.47
  • TOMZ $1.50
  • Technical
  • Relative Strength Index (RSI)
  • RLMD 52.84
  • TOMZ 54.54
  • Support Level
  • RLMD $0.67
  • TOMZ $1.00
  • Resistance Level
  • RLMD $0.72
  • TOMZ $1.12
  • Average True Range (ATR)
  • RLMD 0.08
  • TOMZ 0.06
  • MACD
  • RLMD -0.03
  • TOMZ -0.01
  • Stochastic Oscillator
  • RLMD 40.29
  • TOMZ 21.05

About RLMD Relmada Therapeutics Inc.

Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its lead product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.

About TOMZ TOMI Environmental Solutions Inc.

TOMI Environmental Solutions Inc is a leader in bacteria decontamination and infectious disease control, offering environmentally friendly solutions for indoor air and surface disinfection and decontamination. Its flagship product, SteraMist, uses patented and registered Binary Ionization Technology (BIT) to deliver a low-percentage (7.8%) hydrogen peroxide-based fog or mist to affect all indoor environments and surface areas. Its product portfolio includes The SteraPak, The Surface Unit, The Transport, The NV+, The Environment System, SteraMist Integrated System, BIT Solution, and Custom Engineered System.

Share on Social Networks: